Dynavax Technologies Corporation (LON: 0IDA)
London
· Delayed Price · Currency is GBP · Price in USD
13.07
-0.01 (-0.08%)
Jan 31, 2025, 5:49 PM BST
Dynavax Technologies Revenue
Dynavax Technologies had revenue of $80.63M USD in the quarter ending September 30, 2024, with 15.99% growth. This brings the company's revenue in the last twelve months to $260.81M, down -27.79% year-over-year. In the year 2023, Dynavax Technologies had annual revenue of $232.28M, down -67.86%.
Revenue (ttm)
$260.81M
Revenue Growth
-27.79%
P/S Ratio
n/a
Revenue / Employee
$639.24K
Employees
408
Market Cap
1.38B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 232.28M | -490.40M | -67.86% |
Dec 31, 2022 | 722.68M | 283.24M | 64.45% |
Dec 31, 2021 | 439.44M | 399.19M | 991.75% |
Dec 31, 2020 | 40.25M | 5.03M | 14.29% |
Dec 31, 2019 | 35.22M | 27.02M | 329.60% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Dynavax Technologies News
- 20 days ago - Dynavax Technologies Corp (DVAX) Reports Strong 2024 Financial Performance - GuruFocus
- 20 days ago - Dynavax Technologies guides Q4 and 2024 FY topline - Seeking Alpha
- 20 days ago - Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights - PRNewsWire
- 2 months ago - Dynavax to Present at the 7th Annual Evercore HealthCONx Conference - PRNewsWire
- 2 months ago - Dynavax Technologies: What The Stock Buyback Means. What It Doesn't - Seeking Alpha
- 2 months ago - Dynavax Announces $100 Million Accelerated Share Repurchase Program - PRNewsWire
- 3 months ago - Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates - PRNewsWire